Shield Therapeutics Market Cap

Shield Therapeutics has a market cap or net worth of 94.56 million as of April 28, 2026. Its market cap has increased by 236.19% in one year.

Market Cap

94.56M

Enterprise Value

108.31M

Revenue

36.93M

Ranking

n/a

PE Ratio

n/a

Stock Price

8.70

Market Cap Chart

Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 94.56M, a decrease of -44.30%. That is a compound annual growth rate of -5.59%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	94.56M	-9.59%
Dec 31, 2025	104.59M	395.31%
Dec 31, 2024	21.12M	-59.70%
Dec 29, 2023	52.40M	186.53%
Dec 30, 2022	18.29M	-80.96%
Dec 31, 2021	96.06M	28.62%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Venture Life Group	76.14M
ECO Animal Health Group	63.69M
Provexis	24.63M
Allergy Therapeutics	664.92M
HUTCHMED (China)	1.73B
Hikma Pharmaceuticals	2.99B
Chill Brands Group	2.48M
Haleon	31.61B

Market Cap Rankings